Start-Up Previews (07/2007)
Executive Summary
A preview of the emerging health care companies profiled in the current, all-profiles issue of Start-Up. This month's profile groups are "Start-Ups in Obesity," "New Technologies for Infertility," and "New Zealand Biotech." Plus these Start-Ups Across Health Care: Intelect Medical, N Spine, and Solace Pharmaceuticals.
You may also be interested in...
Avandia and the Commercial Impact of FDA's Credibility Gap
GlaxoSmithKline's diabetes drug Avandia survived a perilous FDA advisory committee review. The real question is whether the industry can survive the damage to FDA's credibility.
Molecular Biometrics LLC
The success rates for in vitro fertilization are rather low--about 34%--and although this isn't much worse than the odds that nature offers for getting pregnant, for the couple that has elected to undergo IVF this risk-benefit proposition is difficult to bear. Molecular Biometrics helps to improve the outcomes of IVF with a diagnostic that determines embryo health.
Mirabilis Medica Inc.
The outstanding success of Novacept, the developer of a device that enabled an office-based procedure for endometrial ablation, demonstrates that Ob-Gyns are eager to offer minimally-invasive, safe, and rapid procedures to their patients as an alternative to the two extremes of surgically removing the uterus or doing nothing. Now Mirabilis Medical, headed up by a Novacept co-founder, hopes to accomplish the same thing for uterine fibroids.